{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T02:21:43Z","timestamp":1777515703073,"version":"3.51.4"},"reference-count":28,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Clinics of North America"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.mcna.2020.10.003","type":"journal-article","created":{"date-parts":[[2021,1,14]],"date-time":"2021-01-14T10:18:05Z","timestamp":1610619485000},"page":"387-396","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Antinuclear Antibody Testing for the Diagnosis of Systemic Lupus Erythematosus"],"prefix":"10.1016","volume":"105","author":[{"given":"Rand A.","family":"Nashi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert H.","family":"Shmerling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.mcna.2020.10.003_bib1","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1097\/BOR.0000000000000480","article-title":"Epidemiology of systemic lupus erythematosus: an update","volume":"30","author":"Stojan","year":"2018","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.mcna.2020.10.003_bib2","first-page":"S72","article-title":"An update on mortality in systemic lupus erythematosus","volume":"26","author":"Ippolito","year":"2008","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.mcna.2020.10.003_bib3","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/s41590-020-0677-6","article-title":"Autoimmunity and organ damage in systemic lupus erythematosus","volume":"21","author":"Tsokos","year":"2020","journal-title":"Nat Immunol"},{"key":"10.1016\/j.mcna.2020.10.003_bib4","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/0002-9343(75)90261-2","article-title":"Studies of twins with systemic lupus erythematosus. A review of the literature and presentation of 12 additional sets","volume":"59","author":"Block","year":"1975","journal-title":"Am J Med"},{"key":"10.1016\/j.mcna.2020.10.003_bib5","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/art.1780350310","article-title":"A\u00a0revised estimate of twin concordance in systemic lupus erythematosus","volume":"35","author":"Deapen","year":"1992","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.mcna.2020.10.003_bib6","first-page":"3638562","article-title":"Programmed Cell Death Pathways in the Pathogenesis of Systemic Lupus Erythematosus","volume":"2019","author":"Yang","year":"2019","journal-title":"J\u00a0Immunol Res"},{"key":"10.1016\/j.mcna.2020.10.003_bib7","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1002\/art.40930","article-title":"2019 European League Against Rheumatism\/American College of Rheumatology classification criteria for systemic lupus erythematosus","volume":"71","author":"Aringer","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.mcna.2020.10.003_bib8","doi-asserted-by":"crossref","first-page":"219","DOI":"10.3109\/s10165-009-0155-3","article-title":"Clinical interpretation of antinuclear antibody tests in systemic rheumatic diseases","volume":"19","author":"Satoh","year":"2009","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.mcna.2020.10.003_bib10","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1002\/acr.23292","article-title":"Performance of Antinuclear Antibodies for Classifying Systemic Lupus Erythematosus: A Systematic Literature Review and Meta-Regression of Diagnostic Data","volume":"70","author":"Leuchten","year":"2018","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.mcna.2020.10.003_bib11","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1001\/archinte.1996.00440120079007","article-title":"Antinuclear antibody testing. A study of clinical utility","volume":"156","author":"Slater","year":"1996","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.mcna.2020.10.003_bib12","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1080\/23744235.2019.1690676","article-title":"Antinuclear antibodies in infectious diseases","volume":"52","author":"Im","year":"2020","journal-title":"Infect Dis"},{"key":"10.1016\/j.mcna.2020.10.003_bib13","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1191\/0961203304lu521oa","article-title":"Clinical significance of antinuclear antibodies in malignant diseases: association with rheumatic and connective tissue paraneoplastic syndromes","volume":"13","author":"Solans-Laqu\u00e9","year":"2004","journal-title":"Lupus"},{"key":"10.1016\/j.mcna.2020.10.003_bib14","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1002\/art.41214","article-title":"Increasing Prevalence of Antinuclear Antibodies in the United States","volume":"72","author":"Dinse","year":"2020","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.mcna.2020.10.003_bib15","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.jaut.2006.10.002","article-title":"Antinuclear antibodies in the oldest-old women and men","volume":"27","author":"Nilsson","year":"2006","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.mcna.2020.10.003_bib16","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/art.30084","article-title":"Pattern on the antinuclear antibody\u2013HEp-2 test is a critical parameter for discriminating antinuclear antibody\u2013positive healthy individuals and patients with autoimmune rheumatic diseases","volume":"63","author":"Mariz","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.mcna.2020.10.003_bib18","doi-asserted-by":"crossref","first-page":"32031","DOI":"10.3402\/jchimp.v6.32031","article-title":"Inappropriate use of commercial Antinuclear Antibody Testing in a community-based US hospital: a retrospective study","volume":"6","author":"Mohammed","year":"2016","journal-title":"J\u00a0Community Hosp Intern Med Perspect"},{"key":"10.1016\/j.mcna.2020.10.003_bib19","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/s10067-012-2141-y","article-title":"An evaluation of autoimmune antibody testing patterns in a Canadian health region and an evaluation of a laboratory algorithm aimed at reducing unnecessary testing","volume":"32","author":"Man","year":"2013","journal-title":"Clin Rheumatol"},{"issue":"suppl 10","key":"10.1016\/j.mcna.2020.10.003_bib20","article-title":"ANA-lysis: Utility of Repeated Antinuclear Antibody Testing in a Single Center [abstract]","volume":"71","author":"Yeo","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.mcna.2020.10.003_bib21","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1002\/art.10561","article-title":"Evidence-based guidelines for the use of immunologic tests: Antinuclear antibody testing","volume":"47","author":"Solomon","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.mcna.2020.10.003_bib22","first-page":"284","article-title":"Systemic lupus erythematosus: primary care approach to diagnosis and management","volume":"94","author":"Lam","year":"2016","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.mcna.2020.10.003_bib23","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1093\/ajcp\/aqw122","article-title":"Algorithmic approach with clinical pathology consultation improves access to specialty care for patients with systemic lupus erythematosus","volume":"146","author":"Chen","year":"2016","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.mcna.2020.10.003_bib24","first-page":"21","article-title":"The sensitivity and specificity of autoantibodies to the Sm antigen in the diagnosis of systemic lupus erythematosus","volume":"27","author":"Pan","year":"1998","journal-title":"Ann Acad Med Singapore"},{"key":"10.1016\/j.mcna.2020.10.003_bib25","doi-asserted-by":"crossref","first-page":"292","DOI":"10.12932\/AP0272.31.4.2013","article-title":"Sensitivity and specificity of ANA and anti-dsDNA in the diagnosis of systemic lupus erythematosus: a comparison using control sera obtained from healthy individuals and patients with multiple medical problems","volume":"31","author":"Wichainun","year":"2013","journal-title":"Asian Pac J Allergy Immunol"},{"key":"10.1016\/j.mcna.2020.10.003_bib26","doi-asserted-by":"crossref","first-page":"e156","DOI":"10.4317\/medoral.20199","article-title":"Role of salivary anti-SSA\/B antibodies for diagnosing primary Sj\u00f6gren's syndrome","volume":"20","author":"Wei","year":"2015","journal-title":"Med Oral Patol Oral Cir Bucal"},{"key":"10.1016\/j.mcna.2020.10.003_bib27","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1007\/s00296-018-4059-4","article-title":"The impact of anti-U1-RNP positivity: systemic lupus erythematosus versus mixed connective tissue disease","volume":"38","author":"Dima","year":"2018","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.mcna.2020.10.003_bib28","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1002\/art.20836","article-title":"Guidelines for immunologic laboratory testing in the rheumatic diseases: Anti-Sm and anti-RNP antibody tests","volume":"51","author":"Benito-Garcia","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.mcna.2020.10.003_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5662\/wjm.v7.i1.1","article-title":"Laboratory evaluation in rheumatic diseases","volume":"7","author":"Birtane","year":"2017","journal-title":"World J Methodol"},{"key":"10.1016\/j.mcna.2020.10.003_bib30","first-page":"80","article-title":"The clinical relevance of autoantibodies in scleroderma","volume":"5","author":"Ho","year":"2003","journal-title":"Arthritis Res Ther"}],"container-title":["Medical Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025712520301292?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025712520301292?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T01:45:14Z","timestamp":1758419114000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025712520301292"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["S0025712520301292"],"URL":"https:\/\/doi.org\/10.1016\/j.mcna.2020.10.003","relation":{},"ISSN":["0025-7125"],"issn-type":[{"value":"0025-7125","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antinuclear Antibody Testing for the Diagnosis of Systemic Lupus Erythematosus","name":"articletitle","label":"Article Title"},{"value":"Medical Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mcna.2020.10.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}